metformin has been researched along with zotarolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Akahori, H; Davis, T; Finn, AV; Habib, A; Karmali, V; Kolodgie, FD; Nakano, M; Narula, J; Otsuka, F; Pachura, K; Polavarapu, R; Virmani, R; Yazdani, S | 1 |
Akahori, H; Finn, AV; Habib, A; Karmali, V; Pachura, K; Polavarapu, R | 1 |
3 other study(ies) available for metformin and zotarolimus
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.
Topics: Administration, Oral; Animals; Aorta; Apoptosis; Cell Proliferation; Cells, Cultured; Drug Interactions; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Humans; Iliac Artery; Metformin; Microscopy, Electron, Scanning; Rabbits; Ribosomal Protein S6 Kinases; Sirolimus | 2013 |
Metformin impairs endothelialization after placement of newer generation drug eluting stents.
Topics: Angioplasty, Balloon; Animals; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Hypoglycemic Agents; Iliac Artery; Immunosuppressive Agents; Male; Metformin; Paclitaxel; Rabbits; Sirolimus; Thrombosis; Tubulin Modulators | 2013 |